Psoriasis: Adalimumab Biosimilars Comparable With Originator ...Middle East

Medscape - News
Biosimilars show comparable safety with Humira among new users with psoriasis in a multinational cohort study, but discontinuations were higher among those who switched from Humira to a biosimilar. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Psoriasis: Adalimumab Biosimilars Comparable With Originator )

Also on site :



Latest News